NVIDIA Corporation (NASDAQ: NVDA) announced a partnership with Foxconn to deploy AI-powered healthcare systems across Taiwan's medical centers as part of the government's $1.5 billion "Healthy Taiwan" initiative.

The collaboration involves implementing Foxconn's CoDoctor AI platform, which uses specialized AI agents for cardiovascular care, oncology, and ophthalmology to assist clinicians with diagnosis, documentation, and care coordination. New agents include ECG screening systems, 3D heart reconstruction tools that reduce workflow time from two hours to one minute, and real-time colonoscopy lesion detection.

Foxconn is also deploying physical AI systems including the Nurabot nursing robot and Scrub Bot surgical assistant. The Nurabot completed field validation at Taichung Veterans General Hospital and is expanding to additional facilities including Taipei Veterans General Hospital. The system handles transport and logistics tasks, freeing an estimated two to three hours per day for nurses to focus on patient care.

The initiative utilizes NVIDIA's Nemotron models for clinical reasoning and NemoClaw technology for autonomous agent deployment. Foxconn creates digital twins of hospital facilities using NVIDIA Omniverse technology for testing and validation before real-world deployment, which has reduced deployment time by 40% and achieved 98% navigation accuracy.

Taiwan's medical centers currently handle more than 14 million patient encounters annually using AI systems. The deployment spans Chang Gung Memorial Hospital, National Taiwan University Hospital, Taipei Veterans General Hospital, and other major medical centers.

"The next era of healthcare is being powered by agentic AI — teams of digital and physical AI agents working alongside clinicians," said Kimberly Powell, vice president of healthcare at NVIDIA.

The information is based on a press release statement from NVIDIA.